Covered recipient · General Payments record
AMANDA L SANFORD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,227.12
- Reported across 73 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $375.53 | 24 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $149.15 | 10 |
| ABBVIE INC. | $62.37 | 4 |
| Amgen Inc. | $34.04 | 2 |
| GlaxoSmithKline, LLC. | $33.48 | 2 |
| Acerta Pharma LLC | $31.64 | 2 |
| Lilly USA, LLC | $31.08 | 2 |
| Xeris Pharmaceuticals, Inc. | $19.38 | 1 |
| PFIZER INC. | $14.39 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (24)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $15.41 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108142542 | CMS |
| ABBVIE INC. | $13.66 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108142544 | CMS |
| ABBVIE INC. | $17.42 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108142546 | CMS |
| ABBVIE INC. | $15.88 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108142548 | CMS |
| Amgen Inc. | $19.04 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117674975 | CMS |
| Amgen Inc. | $15.00 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117674977 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.32 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105844255 | CMS |
| AstraZeneca Pharmaceuticals LP | $18.32 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105730707 | CMS |
| GlaxoSmithKline, LLC. | $19.30 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116495378 | CMS |
| GlaxoSmithKline, LLC. | $14.18 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116450195 | CMS |
| Lilly USA, LLC | $16.83 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135528621 | CMS |
| Lilly USA, LLC | $14.25 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135528623 | CMS |
| Novo Nordisk Inc | $15.31 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100304351 | CMS |
| Novo Nordisk Inc | $11.51 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100605020 | CMS |
| Novo Nordisk Inc | $14.22 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100234778 | CMS |
| Novo Nordisk Inc | $12.18 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100521243 | CMS |
| Novo Nordisk Inc | $14.18 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100312813 | CMS |
| Novo Nordisk Inc | $17.06 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100641934 | CMS |
| Novo Nordisk Inc | $11.29 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100238926 | CMS |
| Novo Nordisk Inc | $17.95 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100330532 | CMS |
| Novo Nordisk Inc | $21.48 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100524719 | CMS |
| Novo Nordisk Inc | $13.97 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100629498 | CMS |
| PFIZER INC. | $14.39 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131167346 | CMS |
| Xeris Pharmaceuticals, Inc. | $19.38 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144619581 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.